{{Rsnum
|rsid=3130062
|Gene=NFKBIL1
|Chromosome=6
|position=31558135
|Orientation=plus
|GMAF=0.02938
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NFKBIL1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.1 | 16.9 | 80.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=3130062
|allele=T
|frequency=0.883
|uid=1103652826824
|type=homozygous_SNP
|hugo=NFKBIL1
|ensembl gene=ENSG00000204498
|ensembl transcript=ENST00000376148
|sift=TOLERATED
|disease=Mutations in the promoter region of NFKBIL1 represent the second rheumatoid arthritis susceptibility locus within the HLA region (MIM:180300).
}}

{{PMID Auto
|PMID=19886988
|Title=Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study.
|OA=1
}}

{{GET Evidence
|gene=NFKBIL1
|aa_change=Arg224Cys
|aa_change_short=R224C
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3130062
|overall_frequency_n=7152
|overall_frequency_d=7518
|overall_frequency=0.951317
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=90
|n_articles=0
|n_articles_annotated=0
|nblosum100=8
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}